European Archives - Page 191 of 1213 - European Medical Journal

Yo-Yo Dieting Raises Kidney Disease Risk in People with Type 1 Diabetes

Body-weight cycling significantly increases the risk of kidney disease in individuals with Type 1 diabetes, study finds.

How Gut Immunity Shapes Severe Allergic Reactions

Targeting RELMβ may provide new therapeutic strategies to prevent severe allergic reactions and improve patient outcomes.

Vascular Changes and Fibrosis Progression in Liver Disease

By integrating advanced imaging, digital pathology, and molecular analysis, research can refine fibrosis staging and treatment approaches.

Intranasal Oxytocin Shows Promise for Apathy in Frontotemporal Dementia

Intranasal oxytocin every third day modestly reduced apathy in frontotemporal dementia patients, offering a potential treatment approach.

Secukinumab Proves Effective in Real-World Psoriatic Arthritis Treatment

Secukinumab shows high drug survival and sustained effectiveness in psoriatic arthritis patients, with better outcomes in mixed peripheral and axial involvement.

Study Shows COVID-19 Pandemic Impacted Reproductive Decisions in Sweden

A study from Southern Sweden has revealed that the COVID-19 pandemic led to a decline in birth rates and significant shifts in abortion trends.

Repeated COVID-19 Infections Increase Long COVID Risk

Individuals who experience multiple COVID-19 infections are at greater risk of developing post-acute sequelae of COVID-19.

Ethnic Disparities in Colorectal Cancer Diagnosis Uncovered in NHS Study

A major NHS study has found significant ethnic disparities in colorectal cancer diagnosis, with non-white patients more likely to develop early-onset CRC but less likely to be diagnosed through urgent referrals.

Scalp Microbiome and Central Centrifugal Cicatricial Alopecia

A recent study examined the scalp microbiome in Black women diagnosed with central centrifugal cicatricial alopecia, compared with matched healthy individuals.

Myval Transcatheter Heart Valve Matches SAPIEN and Evolut in 30-Day Performance

The Myval THV series is non-inferior to SAPIEN and Evolut THV series at 30 days, offering a promising TAVI alternative.